February 2013

Abbott, Janssen, Pharmacyclics to develop companion test for leukemia therapy

Friday, February 22, 2013

Global healthcare company Abbott has formed a collaboration with Janssen Biotech and Pharmacyclics, a biopharmaceutical company based in Sunnyvale, Calif., to explore the benefits of Abbott’s proprietary FISH (fluorescence in situ hybridization) technology for use in developing a molecular companion diagnostic test to identify patients with a genetic subtype of chronic lymphocytic leukemia (CLL), the most common form of adult leukemia.

[Read More]

NIH funds research to identify Parkinson’s biomarkers

Wednesday, February 20, 2013

The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), awarded a three-year, $900,000 grant to the Center for Biomedical Imaging Statistics at Emory’s Rollins School of Public Health. The grant will fund the center’s biomarker research in Parkinson’s disease to identify non-invasive imaging measures that can detect changes in brain function and biochemistry.

[Read More]